2. Apoptosis Anti-infection Neuronal Signaling Epigenetics TGF-beta/Smad Metabolic Enzyme/Protease Cell Cycle/DNA Damage
  3. Apoptosis Influenza Virus Antibiotic Monoamine Oxidase PKC Cytochrome P450 Dopamine β-hydroxylase Reverse Transcriptase Telomerase
  4. Hypericin

ヒペリシン  (Synonyms: Hypericin)

製品番号: HY-N0453 純度: 98.79%
COA 取扱説明書 Technical Support

Hypericin is a naturally occurring substance found in Hyperlcurn perforatum L. Hypericin is an inhibitor of PKC (protein kinase C), MAO (monoaminoxidase), dopamine-beta-hydroxylase, reverse transcriptase, telomerase and CYP (cytochrome P450). Hypericin shows antitumor, antiviral, antidepressive activities, and can induce apoptosis.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 548-04-9

容量 価格（税別） 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 175 在庫あり
Solution
10 mM * 1 mL in DMSO USD 175 在庫あり
Solid
1 mg $66 在庫あり
5 mg $158 在庫あり
10 mg $238 在庫あり
25 mg $462 在庫あり
50 mg   お問い合わせ  
100 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 8 publication(s) in Google Scholar

Other Forms of Hypericin:

ヒペリシン 関連抗体

Top Publications Citing Use of Products

    Hypericin purchased from MedChemExpress. Usage Cited in: Int J Nanomedicine. 2025 Feb 4:20:1529-1541.  [Abstract]

    WM-266-4 cells were co-cultured with different concentrations of HPDENs for 12 hours. The PBS group served as the negative control, while the Hypericin (0.2 μg/mL) group served as the positive control. Cells were then irradiated with an LED at 4 mW/cm² for 10 minutes or left untreated. Data are expressed as means ± SEM.

    Hypericin purchased from MedChemExpress. Usage Cited in: Int J Nanomedicine. 2025 Feb 4:20:1529-1541.  [Abstract]

    Fluorescence microscopy images depict cellular reactive oxygen species levels following treatment with PBS, Hypericin (0.2 μg/mL), and HPDENs with or without LED illumination. Scale bar: 100 μm. Graphic represents cellular ROS levels observed in fluorescence microscopy images. n=3. Data are expressed as means ± SEM.

    Hypericin purchased from MedChemExpress. Usage Cited in: Int J Nanomedicine. 2025 Feb 4:20:1529-1541.  [Abstract]

    Hypericin (0.2 μg/mL). Flow cytometry was employed to assess the expression of apoptosis-related genes in Annexin V-labeled cells. Quantitation of FITC-positive results obtained through flow cytometry. n=3. Data are expressed as means ± SEM.

    Hypericin purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2023 Nov:167:115545.  [Abstract]

    Hypericin (0.2 mg/kg, gavage). Changes in body weight. (csingle bondh) Behavioral tests: SPT. Quantitation of crossing number of rats in OFT. Rearing number of rats in OFT. The average speed of rats in OFT. Immobility time in FST.

    Hypericin purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2023 Nov:167:115545.  [Abstract]

    Hypericin (0.2 mg/kg, gavage). Western blots and analysis showed that lower levels of Cx43 were restored by HY treatment in CUS rats. Representative bands of Cx43, p-Cx43 at Serine-368, and GAPDH. GAPDH was used as a loading control. Quantitation of Cx43/GAPDH, p-Cx43/GAPDH and p-Cx43/Cx43.

    Hypericin purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2023 Nov:167:115545.  [Abstract]

    Hypericin (0.2 mg/kg, gavage). Immunofluorescent staining of p-Cx43. Cx43 or p-Cx43 was labeled with green fluorescence and nuclei were labeled by Hoechst 33342 with blue fluorescence. Scale bar: 200 µm.

    Hypericin purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2023 Nov:167:115545.  [Abstract]

    Cell viability of CORT-treated astrocytes was improved by Hypericin (0.1, 0.5, 2.5 μM). Results were expressed as percentages of the Ctrl group. Data were obtained from six independent experiments and shown as the mean ± SEM.

    Antibiotic アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    Aminoglycoside Glycopeptide Lipopeptide Macrolide Oxazolidinone Quinolone Tetracycline β-lactam

    Monoamine Oxidase アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    MAO-A MAO-B

    PKC アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    PKC PKCα PKCβ PKCγ PKCδ PKCε PKCη PKCζ PKCθ PKCμ PKC-ι ℩ PKCι

    Cytochrome P450 アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    CYP1 CYP2 CYP3 CYP4 CYP11 CYP17 Aromatase/CYP19A1 CYP26 CYP51 CYP1A2 CYP2D6 CYP2C9 CYP2C19 CYP3A CYP3A4 CYP17A1

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Hypericin is a naturally occurring substance found in Hyperlcurn perforatum L. Hypericin is an inhibitor of PKC (protein kinase C), MAO (monoaminoxidase), dopamine-beta-hydroxylase, reverse transcriptase, telomerase and CYP (cytochrome P450). Hypericin shows antitumor, antiviral, antidepressive activities, and can induce apoptosis[1][2][3].

    Cellular Effect
    Cell Line Type Value Description References
    CHO IC50
    0.3 μM
    Compound: 1
    Inhibition of recombinant CRF1 receptor expressed in CHO cells assessed as inhibition of CRF-induced cAMP formation
    Inhibition of recombinant CRF1 receptor expressed in CHO cells assessed as inhibition of CRF-induced cAMP formation
    		[PMID: 20408551]
    HaCaT IC50
    1.7 μM
    Compound: 6p ; Hypericin
    Antiproliferative (inhibition of cell growth) activity against HaCaT cells (human keratinocyte line)
    Antiproliferative (inhibition of cell growth) activity against HaCaT cells (human keratinocyte line)
    		[PMID: 9371243]
    体外実験

    Hypericin (0.25-4 μM; 24 h) inhibits the growth of fibroblasts (Fb), melanocytes (Mc), and keratinocytes (Kc)[2].
    Hypericin (3 μM; 24 h) treatment can induce cells apoptosis[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    ヒペリシン 関連抗体

    Cell Viability Assay[2]

    Cell Line: Fibroblasts (Fb), melanocytes (Mc), and keratinocytes (Kc)
    Concentration: 0.25 μM; 0.5 μM; 1 μM; 2 μM; 3 μM; 4 μM
    Incubation Time: 24 hours
    Result: Showed the LD50 for Fb and Mc at 1.75 μM and 3.5 μM, respectively, and for Kc at a greater dose than 4 μM.

    Apoptosis Analysis[2]

    Cell Line: Fibroblasts (Fb), melanocytes (Mc), and keratinocytes (Kc)
    Concentration: 3 μM
    Incubation Time: 24 hours
    Result: Showed a significant (p<0.001) early apoptotic Fb population (64%), and a smaller, significant (p<0.05) early apoptotic Mc population (20%).
    体内実験

    Hypericin (Intravenous injection; 10 mg/kg; once) treatment delays tumor growth[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: 18-20 week-old female BALB/c mice injected with CT26 carcinomas[3]
    Dosage: 10 mg/kg
    Administration: Intravenous injection; 10 mg/kg; once
    Result: Showed a four times delayed tumor growth compared to the control groups.
    臨床実験
    分子量

    504.44

    分子式

    C30H16O8
    CAS 番号
    Appearance

    Solid

    Color

    Brown to black

    SMILES

    O=C1C2=C(O)C=C(O)C3=C2C4=C(C5=C6C(O)=CC(C)=C5C7=C4C1=C(O)C=C7C)C8=C3C(O)=CC(O)=C8C6=O
    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.
    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 250 mg/mL (495.60 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.9824 mL 9.9120 mL 19.8240 mL
    5 mM 0.3965 mL 1.9824 mL 3.9648 mL
    10 mM 0.1982 mL 0.9912 mL 1.9824 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始）

    C1

    ×
    体積 （開始）

    V1

    =
    濃度 （終了）

    C2

    ×
    体積 （終了）

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: 2.08 mg/mL (4.12 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: 2.08 mg/mL (4.12 mM); Clear solution; Need ultrasonic

      This protocol yields a clear solution of 2.08 mg/mL.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  50% PEG300    50% Saline

      Solubility: 10 mg/mL (19.82 mM); Suspended solution; Need ultrasonic

    • Protocol 2

      Add each solvent one by one:  0.5% CMC-Na/saline water

      Solubility: 25 mg/mL (49.56 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    % 
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 98.79%

    COA (265 KB) HNMR (265 KB) RP-HPLC (205 KB) MS (69 KB)

    取扱説明書 (2659 KB)
    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.9824 mL 9.9120 mL 19.8240 mL 49.5599 mL
    5 mM 0.3965 mL 1.9824 mL 3.9648 mL 9.9120 mL
    10 mM 0.1982 mL 0.9912 mL 1.9824 mL 4.9560 mL
    15 mM 0.1322 mL 0.6608 mL 1.3216 mL 3.3040 mL
    20 mM 0.0991 mL 0.4956 mL 0.9912 mL 2.4780 mL
    25 mM 0.0793 mL 0.3965 mL 0.7930 mL 1.9824 mL
    30 mM 0.0661 mL 0.3304 mL 0.6608 mL 1.6520 mL
    40 mM 0.0496 mL 0.2478 mL 0.4956 mL 1.2390 mL
    50 mM 0.0396 mL 0.1982 mL 0.3965 mL 0.9912 mL
    60 mM 0.0330 mL 0.1652 mL 0.3304 mL 0.8260 mL
    80 mM 0.0248 mL 0.1239 mL 0.2478 mL 0.6195 mL
    100 mM 0.0198 mL 0.0991 mL 0.1982 mL 0.4956 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Hypericin Related Classifications

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Hypericin548-04-9ApoptosisInfluenza VirusAntibioticMonoamine OxidasePKCCytochrome P450Dopamine β-hydroxylaseReverse TranscriptaseTelomeraseMAOProtein kinase CCYPsDopamine beta-hydroxylaseDopamine beta-monooxygenaseDopamine β-monooxygenaseHypericumprotein kinase Cmonoaminoxidasedopamine-beta-hydroxylasereverse transcriptasetelomerase and CYPcytochrome P450antitumor activityantiviral activityantidepressive activityapoptosisfibroblastsmelanocyteskeratinocytesInhibitorinhibitorinhibit

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

    		  

    カスタマ需要量 *

    お名前 *

    		 

    タイトル

    メールアドレス *

    		 

    電話番号 *

    デパートメント

    		 

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

    		      

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Hypericin
    製品番号:
    HY-N0453
    数量:
    MCE 日本正規代理店:

    カスタマーレビュー

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    製品名

    		  

    Lot #

    お名前 *

    		 

    メールアドレス *

    電話番号 *

    		 

    部門 *

    組纖名 *

    		 

    国或いは地域 *

    備考

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.